Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.25 – $0.84
32% from low
Exchange
OTC Link
OS
Borrow rate
7.14%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $57.8K | $2.4M | $7.9M | $9.5M | $20.1M | $26.3M | $35.8M | $35.9M |
| Cost of revenue | −$118.0K | $1.0M | $1.8M | $7.6M | $16.2M | $13.9M | $37.5M | $43.9M |
| Gross profit | $175.6K | $1.3M | $6.2M | $1.9M | $3.9M | $12.4M | −$1.7M | −$8.0M |
| Gross margin | 304.1% | 56.0% | 77.8% | 20.0% | 19.4% | 47.2% | -4.7% | -22.3% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$10.4M | −$8.3M | $282.0K | −$5.4M | −$8.5M | −$1.5M | −$13.3M | −$14.4M |
| EBITDA | −$11.9M | −$7.3M | −$5.1M | −$9.6M | −$1.9M | $4.5M | −$19.5M | −$13.8M |
| Net income | −$10.5M | −$9.8M | −$10.2M | −$11.2M | −$7.5M | −$5.1M | −$22.6M | −$9.9M |
| Net margin | -18228.4% | -413.8% | -128.6% | -118.3% | -37.4% | -19.2% | -63.0% | -27.5% |
| EPS (diluted) | -4.14 | -2.85 | -2.17 | -1.80 | -1.20 | -0.61 | -2.30 | -0.88 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $3M | $-1.26 | $-1.26–$-1.26 | 1 |
| 2027 | $59M | $3.56 | $3.56–$3.56 | 1 |
| 2028 | $86M | $5.58 | $5.58–$5.58 | 1 |
| 2029 | $65M | $3.44 | $3.44–$3.44 | 1 |
Forward consensus · source: Financial Modeling Prep
AVANT BRANDS INC
No one on the platform currently holds AVTBF.
No tracked institution reports a position in AVTBF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-08-30 | 1-for-30reverse |
No one on the platform has traded AVTBF yet.
| $18M |
| — |
| PCLOFPharmaCielo Ltd. | $0.06 | +27.08% | $11M | — |
| RPNRFRapid Nutrition PLC | $10.00 | +99900.00% | $5M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.1× sales vs its 1.2× historical median P/S.
Fair value ≈ $4.79 · price $0.44 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$AVTBF anybody know if Jeremy Lefebvre is still invested? He never mentions Avant Brands anymore.
View on StockTwits ↗$PLNH $TLRY $AVTBF https://youtube.com/shorts/jCwYUKFodOQ?si=xaqNin0hdTOGI85z
View on StockTwits ↗$AVTBF Volatile cash flows are a common characteristic among cannabis stocks in this fragmented and overcrowded market. That said, fundamentals at Avant are moving in the right direction over the long term, and management has demonstrated significant confidence through the recent full repayment of the secured convertible debenture. If the company can maintain and grow positive quarterly free cash flow (FCF) from this point forward, it would represent a major catalyst for the stock price. Based on current projections, the company appears to be trading attractively at approximately 1.5x projected 2025 FCF, using the published 14 million fully diluted shares outstanding, which account for all warrants and options. Should Avant Brands prove that this positive cash flow is sustainable, a significant re-rating of the equity valuation is highly probable. Even applying a conservative 10x FCF multiple, the stock could potentially reach $4+ within the next 12 months. This is all my personal opinion.
View on StockTwits ↗$LUFFF $TLRY $AVTBF $LOVFF $CGC “The Company stands alone in its ability to simultaneously double medical sales and provincial footprint/SKUs while tripling exports, opportunities its public peers exhausted years ago. This convergence of untapped channels positions Herbal Dispatch for the sharpest revenue acceleration in the entire public cannabis sector over the next 24-36 months.”
View on StockTwits ↗$TLRY $LUFFF $AVTBF $LOVFF $CGC All these companies got a % of this chart, up to $100M a month in exports! Expected to reach $150M a month by the end of the year!
View on StockTwits ↗$AVTBF is this stock going to move with US MSO's on rescheduling ?
View on StockTwits ↗$AVTBF if this doesnt run up with the MSO's upon rescheduling and safer banking. Im dumping this turd tired of looking at it.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.